companydata.dkcompanydata.dk

BIOMEDIQ A/S: Financial statements 2013

CVR: 31176891

Source: annual report 2013, Danish Business Authority

01/01/2013 – 31/12/2013

BIOMEDIQ A/S (CVR 31176891) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 5,934,540 and a net result of DKK 24,423 compared with DKK 50,652 the year before. That is a decrease of 10.6% compared with the year before. The profit margin was 0.4%. Equity in the 2013 report amounted to DKK 434,878. The solvency ratio was 12.3%.

Revenue
DKK 5,934,540
Gross Profit
DKK 3,569,742
Profit/Loss
DKK 24,423
Equity
DKK 434,878
Total Assets
DKK 3,534,971

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20135.9M3.6M24K435K-
20126.6M3.5M51K410K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2013

BIOMEDIQ A/S: The 2012 annual report is outJun 4, 2013

BIOMEDIQ A/S has published its annual report for 2012. Revenue came to DKK 6,637,825, and the net result was DKK 50,652.

About BIOMEDIQ A/S

BIOMEDIQ A/S is a Danish company of the type Aktieselskab based in København K, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named SYNARC IMAGING TECHNOLOGY A/S and NORDIC BIOSCIENCE IMAGING A/S. The management consists of Mads Nielsen. The board consists of Pieter Kroese (chair), Mads Nielsen and Martin Lillholm. The company is owned by Screenpoint Medical B.V. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -304,901 and a net result of DKK -977,037 compared with DKK -56,669 the year before. Equity in the 2025 report amounted to DKK -979,433.

Source: annual report 2025, Danish Business Authority